Advertisement
Perrigo Guides FY24 Well Below Estimates - Update
(RTTNews) - While reporting financial results for the fourth quarter on Tuesday, consumer products company Perrigo Co. plc (PRGO) initiated its adjusted earnings, revenue and organic net sales growth guidance for the full-year 2024.
For fiscal 2024, the company now projects adjusted earnings in a range of $2.50 to $2.65 per share on flat net sales, with organic net sales growth of 1 to 3 percent.
On average, analysts polled by Thomson Reuters expect the company to report earnings of $2.99 per share on revenue growth of 4.7 percent to $4.89 billion for the quarter. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
Perrigo Recalls Select CVS Health, H-E-B Baby Premium Infant Formula
Perrigo Co. plc is recalling select Premium Infant Formula with Iron Milk-Based Powder sold under CVS Health and H-E-B Baby brands at the retailer and warehouse level citing elevated Vitamin D levels than permitted, according to the U.S. Food and Drug Administration. The recall involves three lots within one batch, or 16,500 cans, of store brand Premium Infant Formula with Iron Milk-Based Powder.
RTTNews
|
324 days ago
Perrigo Launches Project Energize To Improve Efficiency, Cut Costs; To Cut 6% Jobs - Update
While reporting financial results for the fourth quarter on Tuesday, consumer products company Perrigo Co. plc (PRGO) said it is launching Project Energize - a global investment and efficiency program to drive the next evolution of capabilities and organizational agility.
RTTNews
|
488 days ago
Perrigo Appoints Patrick Lockwood-Taylor As President And CEO
Pharma company Perrigo Company plc (PRGO) announced Thursday the appointment of industry professional Patrick Lockwood-Taylor as its new President, Chief Executive Officer and member of the Board of Directors, effective June 30, 2023.
RTTNews
|
752 days ago
Perrigo Says HRA Pharma Submits Application To FDA For OTC Birth Control Pill In The U.S.
Consumer Self-Care Products firm Perrigo Co. plc (PRGO) announced Monday that its company HRA Pharma has submitted its application to the U.S. Food and Drug Administration (FDA) for the first-ever over-the-counter (OTC) birth control pill in the U.S.
RTTNews
|
1084 days ago
Sensex, Nifty Subdued After Last Week's Rally
Indian shares were subdued on Monday after rising sharply last week, buoyed by receding tensions in the Middle East and a sharp correction in global crude oil prices.
RTTNews
|
38 minutes ago
Australian Market Extends Early Gains In Mid-market
The Australian stock market is extending its early gains in mid-market trading on Monday, reversing some of the losses in the previous two sessions, following the broadly positive cues from Wall Street on Friday. The benchmark S&P/ASX 200 index is moving above the 8,550.00 level, with gains is financial and technology stocks partially offset by weakness in mining stocks.
RTTNews
|
1h 46min ago
Asian Markets Mixed Amid Cautious Trades
Asian stock markets are trading mixed on Monday, following the broadly negative cues from Wall Street on Friday, as traders remain cautious amid renewed optimism about new trade deals after US President Donald Trump indicated he does not think he will need to extend the July 9 deadline for countries to secure trade deals with the US. Trump also indicated the US had signed an agreement with China.
RTTNews
|
2h 17min ago
Sensex, Nifty Set For Muted Start
Indian shares look set to open largely unchanged on Monday, though losses, if any, may remain limited owning to record-high U.S. stock performance and progress in trade negotiations.
RTTNews
|
2h 32min ago
